Page last updated: 2024-10-24

carbazochrome and Dengue Hemorrhagic Fever

carbazochrome has been researched along with Dengue Hemorrhagic Fever in 1 studies

carbazochrome: a hemostatic which increases capillary resistance & activates platelet factors, Note: Adona is a multimeaning tradename

Research Excerpts

ExcerptRelevanceReference
"We studied the ability of carbazochrome sodium sulfonate (AC-17) to prevent capillary permeability in dengue hemorrhagic fever/dengue shock syndrome."5.08Failure of carbazochrome sodium sulfonate (AC-17) to prevent dengue vascular permeability or shock: a randomized, controlled trial. ( Chirawatkul, A; Dhiensiri, T; Nisalak, A; Tassniyom, S; Vasanawathana, S, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tassniyom, S1
Vasanawathana, S1
Dhiensiri, T1
Nisalak, A1
Chirawatkul, A1

Trials

1 trial available for carbazochrome and Dengue Hemorrhagic Fever

ArticleYear
Failure of carbazochrome sodium sulfonate (AC-17) to prevent dengue vascular permeability or shock: a randomized, controlled trial.
    The Journal of pediatrics, 1997, Volume: 131, Issue:4

    Topics: Adrenochrome; Capillary Permeability; Child; Child, Preschool; Female; Hemostatics; Hospitalization;

1997